The Gaudium IVF IPO 2026 is set to open from February 20 to February 24, 2026, offering investors exposure to India’s fast-growing fertility and assisted reproductive technology (ART) market. With strong margins, expanding centers, and a scalable hub-and-spoke model, Gaudium IVF & Women Health Ltd. is positioning itself as a high-return healthcare play.

In this detailed IPO Ji review, you’ll find:

• IPO dates, price band & lot size
• GMP today & listing expectations
• Live subscription data
• Financial performance & key ratios
• Valuation analysis

Gaudium IVF IPO – Key Highlights

• IPO Size: ₹165 crore
• Issue Type: Fresh Issue + Offer for Sale
• Fresh Issue: ₹90 crore
• OFS: ₹75 crore
• Price Band: ₹75 to ₹79 per share
• Face Value: ₹5
• Lot Size: 189 shares
• Minimum Investment: ₹14,931
• Pre-IPO Market Cap: ₹575.02 crore
• Listing: BSE & NSE
• Tentative Listing Date: February 27, 2026

Gaudium IVF IPO Dates

Application Forms

Gaudium IVF IPO Lot Size & Investment

About Gaudium IVF & Women Health Ltd.

Founded in 2015 and headquartered in New Delhi, Gaudium IVF & Women Health Ltd. operates in the Assisted Reproductive Technology (ART) segment.

Core Services:

• In Vitro Fertilization (IVF)
• Intracytoplasmic Sperm Injection (ICSI)
• Intrauterine Insemination (IUI)
• Ovulation induction
• Male infertility treatments
• PCOS & endometriosis care
• High-risk pregnancy management

Network & Expansion

• 30+ locations across India
• 7 hubs + 28 spoke centers
• Presence in Delhi, Mumbai, Bangalore, Patna, Ludhiana & Srinagar
• International patients from USA, UK, Canada, Kenya, South Africa & Oman

The company follows an asset-light, scalable hub-and-spoke model, allowing expansion with controlled capital expenditure.

IPO Objectives – Use of Funds

Expansion into new centers is expected to drive long-term revenue growth.

Financial Performance (₹ Crore)

For 6M FY26:

• Revenue: ₹49.75 crore
• PAT: ₹12.51 crore

Key Financial Ratios

Gaudium IVF IPO GMP Today

Current Grey Market Premium (GMP) of Gaudium IVF IPO

GMP is dynamic and should not be the sole basis for decision-making, check for educational purposes.

Competitive Strengths

✔ Strong promoter-led medical expertise

✔ Asset-light scalable model

✔ High EBITDA & PAT margins

✔ Growing IVF awareness in India

✔ Advanced INTEGRA Ti labs for ICSI

Risks to Consider

⚠ Regulatory risks in ART sector

⚠ Reputation-sensitive business

⚠ Dependence on skilled doctors

⚠ Expansion execution challenges

Should You Apply for Gaudium IVF IPO?

The Gaudium IVF IPO presents a fundamentally strong healthcare company with high margins, strong ROE, scalable model, and reasonable valuation at ~23x P/E. With expansion into new IVF centers, growth potential remains significant.

However, investors should consider regulatory and operational risks before investing.

How to Apply for Gaudium IVF IPO?

Gaudium IVF IPO – Frequently Asked Questions (FAQs)

What is Gaudium IVF IPO price band?

The price band of the Gaudium IVF IPO is ₹75 to ₹79 per share.

What are the IPO dates?

The IPO opens on February 20, 2026 and closes on February 24, 2026. The tentative listing date is February 27, 2026 on BSE and NSE.

What is the lot size and minimum investment?

The minimum lot size is 189 shares, and the minimum investment required for retail investors is ₹14,931 (at the upper price band of ₹79).

What is the total issue size of Gaudium IVF IPO?

The IPO size is ₹165 crore, consisting of:

• ₹90 crore fresh issue
• ₹75 crore offer for sale (OFS)

What will the IPO proceeds be used for?

The company will use the proceeds primarily for:

• Establishing new IVF centers (₹50 crore)
• Repayment of certain loans (₹20 crore)
• General corporate purposes

What does Gaudium IVF & Women Health Ltd. do?

Gaudium IVF & Women Health Ltd. provides fertility treatments including IVF, ICSI, IUI, ovulation induction, male infertility treatments, and gynecological care. It operates through a hub-and-spoke model across 30+ locations in India.

What is the retail quota in Gaudium IVF IPO?

The retail portion is not less than 35% of the net issue.

What are the key financial highlights of Gaudium IVF?

For FY25:

• Revenue: ₹70.96 crore
• Profit After Tax: ₹19.13 crore
• ROE: 41.31%
• EBITDA Margin: 40.48%
• Debt/Equity: 0.41

What is the expected listing date?

The shares are tentatively scheduled to list on February 27, 2026.

Who are the promoters of Gaudium IVF?

The promoters are:

• Dr. Manika Khanna
• Dr. Peeyush Khanna
• Vishad Khanna